U.S. flag

An official website of the United States government

NM_000326.5(RLBP1):c.190C>T (p.Arg64Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 19, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001226268.6

Allele description [Variation Report for NM_000326.5(RLBP1):c.190C>T (p.Arg64Ter)]

NM_000326.5(RLBP1):c.190C>T (p.Arg64Ter)

Gene:
RLBP1:retinaldehyde binding protein 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q26.1
Genomic location:
Preferred name:
NM_000326.5(RLBP1):c.190C>T (p.Arg64Ter)
HGVS:
  • NC_000015.10:g.89217276G>A
  • NG_008116.1:g.9416C>T
  • NM_000326.5:c.190C>TMANE SELECT
  • NP_000317.1:p.Arg64Ter
  • NC_000015.9:g.89760507G>A
  • NM_000326.4:c.190C>T
Protein change:
R64*
Links:
dbSNP: rs561618945
NCBI 1000 Genomes Browser:
rs561618945
Molecular consequence:
  • NM_000326.5:c.190C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001398575Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 19, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Non-steroidal anti-inflammatories.

Hynes D.

Practitioner. 1990 Jun 8;234(1490):620-3. No abstract available.

PubMed [citation]
PMID:
2392416

Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation.

Saari JC, Nawrot M, Kennedy BN, Garwin GG, Hurley JB, Huang J, Possin DE, Crabb JW.

Neuron. 2001 Mar;29(3):739-48.

PubMed [citation]
PMID:
11301032
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001398575.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change creates a premature translational stop signal (p.Arg64*) in the RLBP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RLBP1 are known to be pathogenic (PMID: 2392416, 11301032, 21447491, 25429852). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RLBP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 865948). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024